Resvega, a Nutraceutical Preparation, Affects NFκB Pathway and Prolongs the Anti-VEGF Effect of Bevacizumab in Undifferentiated ARPE-19 Retina Cells
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Age-related macular degeneration (AMD) is an irreversible chronic degenerative pathology that affects the retina. Despite therapeutic advances thanks to the use of anti-vascular endothelial growth factor (VEGF) agents, resistance mechanisms have been found to accentuate the visual deficit. In the present study, we explored whether a nutraceutical formulation composed of omega-3 fatty acids and resveratrol, called Resvega®, was able to disrupt VEGF-A secretion in human ARPE-19 retina cells. We found that Resvega® inhibits VEGF-A secretion through decreases in both the PI3K-AKT-mTOR and NFκB signaling pathways. In NFκB signaling pathways, Resvega® inhibits the phosphorylation of the inhibitor of NFκB, IκB, which can bind NFκB dimers and sequester them in the cytoplasm. Thus, the NFκB subunits cannot migrate to the nucleus where they normally bind and stimulate the transcription of target genes such as VEGF-A. The IκB kinase complex (IKK) is also affected by Resvega® since the nutraceutical formulation decreases both IKKα and IKKβ subunits and the IKKγ subunit which is required for the stimulation of IKK. Very interestingly, we highlight that Resvega® could prolong the anti-angiogenic effect of Avastin®, which is an anti-VEGF agent typically used in clinical practice. Our results suggest that Resvega® may have potential interest as nutritional supplementation against AMD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






![Figure 7 Schematic illustration of the novel proposed mechanisms of the anti-angiogenic impact of Resvega® (RGA), which is able to target several angiogenesis molecular pathways in human ARPE-19 retina cell model. RGA counteracts angiogenic VEGF-A production through an alteration of the AKT/PI3K and NFκB pathways. In detail, RGA reduces the regulator complex IKK controlling the downstream NFκB subunits P65 and P50 belonging and their nuclear/cytosolic localization. This new RGA-targeted pathway complements data on the impact of RGA, which we have previously demonstrated to be involved in preventing activation of the MAPK signaling pathway in ARP19 cells [22]. The disruption of these two important angiogenesis signaling pathways likely leads to a sensitization of retina cells to the anti-VEGF treatment, resulting in an increased ability of Avastin® to decrease VEGF-A secretion over time.](https://figures.cochat.ai/paper-figures/d5e494ebbbf04e5da33e63240a60350c/resvega-a-nutraceutical-preparation-affects-nfb-pathway-and-prolongs-the-anti-figure-7.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Nutritional anti-VEGF intervention against wet AMD has been shown to act by preventing MAPK activation in RPE cells [ 54 ], with the involvement of NFκB [ 55 ]”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [55]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
De Cillà, S. D., Farruggio, S., Vujosevic, S., Raina, G., Filippini, D., Gatti, V., Clemente, N., Mary, D., Vezzola, D., Casini, G., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479441 · Cited by 5,136
A cytokine-responsive IκB kinase that activates the transcription factor NF-κB
DiDonato, J. A., Hayakawa, M., Rothwarf, D. M., Zandi, E., & Karin, M. (1997) · Nature · doi:10.1038/41493 · Cited by 2,125
IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB Activation
Mercurio, F., Zhu, H., Murray, B. W., Shevchenko, A., Bennett, B. L., Li, J. W., Young, D. B., Barbosa, M., Mann, M., Manning, A., et al. (1997) · Science · doi:10.1126/science.278.5339.860 · Cited by 2,040
Age-related macular degeneration
Lim, L. S., Mitchell, P., Seddon, J. M., Holz, F. G., & Wong, T. Y. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60282-7 · Cited by 1,717
ARPE-19, A Human Retinal Pigment Epithelial Cell Line with Differentiated Properties
DUNN, K. C., AOTAKI-KEEN, A. E., PUTKEY, F. R., & HJELMELAND, L. M. (1996) · Experimental Eye Research · doi:10.1006/exer.1996.0020 · Cited by 1,330 · cited 1×
“These undifferentiated ARPE-19 cells spontaneously produce human RPE cell lines with normal karyology, which form polarized epithelial monolayers [44].”
BackgroundYamaoka, S., Courtois, G., Bessia, C., Whiteside, S. T., Weil, R., Agou, F., Kirk, H. E., Kay, R. J., & Israël, A. (1998) · Cell · doi:10.1016/s0092-8674(00)81466-x · Cited by 1,076
Fukumura, D., Gohongi, T., Kadambi, A., Izumi, Y., Ang, J., Yun, C.-O., Buerk, D. G., Huang, P. L., & Jain, R. K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041359198 · Cited by 1,020 · cited 2×
“These include, in particular, the ERK1/2 pathway on which we have shown that RGA has an effect [22], but also other pathways, for instance the PI3K‐AKT‐mTOR pathway, which is crucial for cell survival, regulation of vasomotion and angiogenesis [27,28] In order to understand the impact of RGA on Figure 1.”
BackgroundAge-related macular degeneration
Fleckenstein, M., Keenan, T. D. L., Guymer, R. H., Chakravarthy, U., Schmitz-Valckenberg, S., Klaver, C. C., Wong, W. T., & Chew, E. Y. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00265-2 · Cited by 978
IKK-γ is an essential regulatory subunit of the IκB kinase complex
Rothwarf, D. M., Zandi, E., Natoli, G., & Karin, M. (1998) · Nature · doi:10.1038/26261 · Cited by 957
Age-related macular degeneration (AMD): pathogenesis and therapy.
Nowak, J. Z. (2006) · PubMed · Cited by 755
Immunology of age-related macular degeneration
Ambati, J., Atkinson, J. P., & Gelfand, B. D. (2013) · Nature Reviews Immunology · doi:10.1038/nri3459 · Cited by 584 · cited 1×
“However, the major components involved in the pathogenesis of AMD are significant oxidative stress associated with the aging process, which appears to be the triggering factor for the pathology [5–8], and chronic inflammation eventually leading to the formation of the new choroidal vessels (choroidal neovascularizatio…”
BackgroundAngiogenesis selectively requires the p110α isoform of PI3K to control endothelial cell migration
Graupera, M., Guillermet-Guibert, J., Foukas, L. C., Phng, L.-K., Cain, R. J., Salpekar, A., Pearce, W., Meek, S., Millan, J., Cutillas, P. R., et al. (2008) · Nature · doi:10.1038/nature06892 · Cited by 520
Resistance Mechanisms to Anti-angiogenic Therapies in Cancer
Haibe, Y., Kreidieh, M., El Hajj, H., Khalifeh, I., Mukherji, D., Temraz, S., & Shamseddine, A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00221 · Cited by 396
Mechanisms of age‐related macular degeneration and therapeutic opportunities
van Lookeren Campagne, M., LeCouter, J., Yaspan, B. L., & Ye, W. (2014) · The Journal of Pathology · doi:10.1002/path.4266 · Cited by 382
Mettu, P. S., Allingham, M. J., & Cousins, S. W. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100906 · Cited by 370 · cited 1×
“Thus, patients with refractory or recurrent AMD (approximately 1/3 of patients) may develop resistance mechanisms over the long term, leading to a reduction in therapeutic efficacy [16,17].”
BackgroundHuman Retinal Pigment Epithelium Cells as Functional Models for the RPE In Vivo
Ablonczy, Z., Dahrouj, M., Tang, P. H., Liu, Y., Sambamurti, K., Marmorstein, A. D., & Crosson, C. E. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.11-8021 · Cited by 243 · cited 1×
“In undifferentiated human ARPE-19 retinal cells mimicking the cells affected by AMD [24], this nutraceutical formulation was also able to reduce the secretion of VEGF by approximately 20% after 24 h of treatment, without affecting cell viability [22].”
BackgroundFerrara, N. (2010) · Nature Medicine · doi:10.1038/nm1010-1107 · Cited by 203 · cited 1×
“VEGF-A is strongly involved in the abnormal growth of blood vessels and the increase in vascular permeability that leads to loss of vision [23].”
BackgroundSomasundaran, S., Constable, I. J., Mellough, C. B., & Carvalho, L. S. (2020) · Clinical & Experimental Ophthalmology · doi:10.1111/ceo.13834 · Cited by 190 · cited 2×
“This is then accompanied by an alteration of the RPE, with phenomena of hyper- or hypo-pigmentation [1].”
BackgroundAge-Related Macular Degeneration: Role of Oxidative Stress and Blood Vessels
Ruan, Y., Jiang, S., & Gericke, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031296 · Cited by 178
Targeting VEGF in eye neovascularization: What's new?
Amadio, M., Govoni, S., & Pascale, A. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2015.11.027 · Cited by 175
Abokyi, S., To, C.-H., Lam, T. T., & Tse, D. Y. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/7901270 · Cited by 167
Development and Role of Tight Junctions in the Retinal Pigment Epithelium
Rizzolo, L. J. (2007) · International Review of Cytology · doi:10.1016/s0074-7696(07)58004-6 · Cited by 164 · cited 3×
“Thereby, the loss of tight junctions, connected to the actin cytoskeleton through ZO‐1, leads to retinal‐barrier disruption, which is associated with the AMD‐pathogenicity [25,26].”
BackgroundAge-related macular degeneration therapy: a review
Ammar, M. J., Hsu, J., Chiang, A., Ho, A. C., & Regillo, C. D. (2020) · Current Opinion in Ophthalmology · doi:10.1097/icu.0000000000000657 · Cited by 136
Neovascular Age-Related Macular Degeneration (nAMD): A Review of Emerging Treatment Options
Tan, C. S., Ngo, W. K., Chay, I. W., Ting, D. S., & Sadda, S. R. (2022) · Clinical ophthalmology · doi:10.2147/opth.s231913 · Cited by 100
Antitumor Activity of Rapamycin in a Transgenic Mouse Model of ErbB2-Dependent Human Breast Cancer
Liu, M., Howes, A., Lesperance, J., Stallcup, W. B., Hauser, C. A., Kadoya, K., Oshima, R. G., & Abraham, R. T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4589 · Cited by 93 · cited 1×
“Various studies have shown in in vivo tumor models, that targeting this signaling pathway reduces angiogenesis and microvascular density [39,40].”
BackgroundToma, C., Cillà, S. D., Palumbo, A., Garhwal, D. P., & Grossini, E. (2021) · Antioxidants · doi:10.3390/antiox10050653 · Cited by 70
Richer, S., Patel, S., Sockanathan, S., Ulanski, L., Miller, L., & Podella, C. (2014) · Nutrients · doi:10.3390/nu6104404 · Cited by 60
Richer, S., Stiles, W., Ulanski, L., Carroll, D., & Podella, C. (2013) · Nutrients · doi:10.3390/nu5061989 · Cited by 57
Development of Anti-VEGF Therapies for Intraocular Use: A Guide for Clinicians
Keane, P. A., & Sadda, S. R. (2012) · Journal of Ophthalmology · doi:10.1155/2012/483034 · Cited by 51 · cited 1×
“) [33], treatment failure still occurs due to side effects and resistance.”
BackgroundNutraceutical with Resveratrol and Omega-3 Fatty Acids Induces Autophagy in ARPE-19 Cells
Koskela, A. K. J., Reinisalo, M., Petrovski, G., Sinha, D., Olmière, C., Karjalainen, R., & Kaarniranta, K. (2016) · Nutrients · doi:10.3390/nu8050284 · Cited by 44
The Aging Stress Response and Its Implication for AMD Pathogenesis
Blasiak, J., Pawlowska, E., Sobczuk, A., Szczepanska, J., & Kaarniranta, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228840 · Cited by 44 · cited 1×
“However, the major components involved in the pathogenesis of AMD are significant oxidative stress associated with the aging process, which appears to be the triggering factor for the pathology [5–8], and chronic inflammation eventually leading to the formation of the new choroidal vessels (choroidal neovascularizatio…”
BackgroundResveratrol reverses the adverse effects of bevacizumab on cultured ARPE-19 cells
Subramani, M., Murugeswari, P., Krishna, L., Jeyabalan, N., Chevour, P., Sharma, A., Jayadev, C., Shetty, R., Begum, N., Archunan, G., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-12496-z · Cited by 40 · cited 1×
“Furthermore, a recent study was able to show that RSV alone was able to reverse the adverse effect of bevacizumab in ARPE-19 retinal cell [43].”
BackgroundLiegl, R. G.-H., Koenig, S. F., Siedlecki, J., Haritoglou, C., Kampik, A., & Kernt, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088203 · Cited by 37 · cited 1×
“In a similar manner, in the eye, inhibition of this pathway has been described as a new strategy to manage neovascularization in a variety of ocular diseases [41].”
BackgroundResvega Alleviates Hydroquinone-Induced Oxidative Stress in ARPE-19 Cells
Bhattarai, N., Korhonen, E., Toppila, M., Koskela, A. K. J., Kaarniranta, K., Mysore, Y., & Kauppinen, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062066 · Cited by 30 · cited 6×
“The phosphorylation of AKT leads to the expression of inflammatory cytokines (IL‐6, IL‐8, IL‐18), which support the inflammatory environment involved in AMD pathogenesis, and contributes to VEGF secretion by the inflammatory‐induced angiogenesis process [34].”
BackgroundInfluentialSaito, K., Matsumoto, S., Yasui, H., Devasahayam, N., Subramanian, S., Munasinghe, J., Patel, V., Gutkind, J. S., Mitchell, J. B., & Krishna, M. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049456 · Cited by 26 · cited 1×
“Various studies have shown in in vivo tumor models, that targeting this signaling pathway reduces angiogenesis and microvascular density [39,40].”
BackgroundFontaine, V. K., Fournié, M., Monteiro, E., Boumedine, T., Balducci, C., Guibout, L., Latil, M., Sahel, J., Veillet, S., Dilda, P. J., et al. (2021) · Aging · doi:10.18632/aging.203558 · Cited by 22
Courtaut, F., Aires, V., Acar, N., Bretillon, L., Guerrera, I. C., Chhuon, C., Pais de Barros, J.-P., Olmiere, C., & Delmas, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011023 · Cited by 21 · cited 10×
“The decreases in VEGF-A secretion and the PI3K-AKT-mTOR-NFκB pathway by RGA reinforce the results of a recent laser-induced CNV in mouse model study in which supplementation for 14 days with RGA significantly reduced CNV development [18].”
BackgroundMethodResultSelf-citationMa, J., Sun, Y., López, F. J., Adamson, P., Kurali, E., & Lashkari, K. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-18795 · Cited by 20 · cited 1×
“For example, recent studies have shown that the use of a selective inhibitor of class I PI3K and mTOR pathways blocks vascular leakage and reduces CNV lesion size in a laser-induced model of neovascular AMD [42].”
BackgroundPrevention and Treatment of Age-Related Macular Degeneration: An Update for Pharmacists
Marshall, L. L., & Roach, J. (2013) · The Consultant Pharmacist · doi:10.4140/tcp.n.2013.723 · Cited by 19 · cited 1×
“Indeed, the results of the Age-Related Eye Disease Study 1 (AREDS-1), a multicenter, randomized controlled clinical trial, showed the benefit of using large doses of micronutrients in the early stages of the disease [35].”
Musiał-Kopiejka, M., Polanowska, K., Dobrowolski, D., Krysik, K., Wylęgała, E., Grabarek, B. O., & Lyssek-Boroń, A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19042303 · Cited by 19
Bhattarai, N., Piippo, N., Ranta‐aho, S., Mysore, Y., Kaarniranta, K., & Kauppinen, A. (2021) · Antioxidants · doi:10.3390/antiox10010067 · Cited by 18 · cited 1×
“A potential molecular explanation was recently suggested by some authors showing that RGA could reduce inflammation [19] and oxidative stress [20], and, on the contrary, induce autophagy [21] in retinal cell models.”
BackgroundCourtaut, F., Scagliarini, A., Aires, V., Cornebise, C., Pais de Barros, J.-P., Olmiere, C., & Delmas, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126590 · Cited by 17
Self-citationEmerging treatments for geographic atrophy in age-related macular degeneration
Mahmoudzadeh, R., Hinkle, J. W., Hsu, J., & Garg, S. J. (2021) · Current Opinion in Ophthalmology · doi:10.1097/icu.0000000000000746 · Cited by 14 · cited 1×
“Geographic atrophy occurs when the cell loss can no longer be compensated for by the spreading of the remaining cells that previously maintained the continuity of the epithelium [2].”
BackgroundRICHER, S. P., Cho, J., Stiles, W. R., Levin, M. H., Wrobel, J. S., Sinai, M. J., & Thomas, C. (2012) · Nutrients · doi:10.3390/nu4121812 · Cited by 9
Single-cell transcriptomic profiling provides insights into retinal endothelial barrier properties.
Watson, M. I., Barabás, P., McGahon, M. K., McMahon, M., Fuchs, M., Curtis, T. M., & Simpson, D. A. C. (2020) · Research Portal (Queen's University Belfast) · Cited by 2
Cited by
MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges
Moustardas, P., Aberdam, D., & Lagali, N. (2023) · Cells · doi:10.3390/cells12040617 · Cited by 63
“At the same time, a balanced p38/TXNIP/NFκB pathway inhibition is required for proper tight junctions in the inner blood–retinal barrier [87] and for the prevention of macular edema [88–91], while ERK and JNK phosphorylation is inversely correlated with the expression of tight junction components in human retinal endo…”
BackgroundInfluentialBuonfiglio, F., Korb, C. A., Stoffelns, B. M., Pfeiffer, N., & Gericke, A. (2024) · Aging and Disease · doi:10.14336/ad.2024.0124 · Cited by 54
“This group further showed a prolonged effect of bevacizumab in undifferentiated ARPE-19 cells through supplementation with Resvega®, suppressing VEGF-A secretion by attenuating both the PI3K/Akt/mTOR and NFκB signaling pathways [424].”
The Past and Future of Angiogenesis as a Target for Cancer Therapy and Prevention
Albini, A., Noonan, D. M., Corradino, P., Magnoni, F., & Corso, G. (2024) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-24-0085 · Cited by 25
Huang, J.-M., Zhao, N. R., Hao, X.-N., Li, S., Wei, D., Pu, N., Peng, G.-H., & Tao, Y. (2024) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.65.1.29 · Cited by 22
Pinelli, R., Ferrucci, M., Berti, C., Biagioni, F., Scaffidi, E., Bumah, V. V., Busceti, C. L., Lenzi, P., Lazzeri, G., & Fornai, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108979 · Cited by 9
Metadata
- Authors
- Sghaier, R., Perus, M., Cornebise, C., Courtaut, F., Scagliarini, A., Olmiere, C., Aires, V., Hermetet, F., & Delmas, D.
- Affiliations
- Inserm (FR)
- Laboratoires Théa<sup>®</sup>, 12 Rue Louis-Blériot, 63000 Clermont-Ferrand, France
- Corresponding author
- Delmas, Dominique
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-10-03
- Volume
- 23
- Issue
- 19
- Pages
- 11704
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC9569823
- OpenAlex
- W4303699621
- Cited by
- 11
- References
- 45
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 3 · 2023: 3
- FWCI
- 2.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Agence Nationale de la Recherche (ANR-11-LABX-0021)
- Association Nationale de la Recherche et de la Technologie
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- nutraceuticals, resveratrol, omega-3 fatty acids, age-related macular degeneration, VEGF-A secretion, NF-κB signaling, PI3K/AKT/mTOR pathway, IκB phosphorylation, IκB kinase, bevacizumab, ARPE-19 cells, dietary supplementation
- MeSH terms
- Bevacizumab, Resveratrol, Humans, Macular Degeneration, Retina, Fatty Acids, Omega-3, Endothelial Growth Factors, NF-kappa B, Dietary Supplements, Phosphatidylinositol 3-Kinases, Vascular Endothelial Growth Factor A, Proto-Oncogene Proteins c-akt, I-kappa B Kinase, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.